Fioricet Capsule
NDC Package 52544-080-01
Package Information
Fioricet (butalbital, acetaminophen, and caffeine) capsules is this combination medication is used to treat tension headaches. This formulation utilizes a capsule delivery system. Marketed by Actavis Pharma, Inc., this product is identified by NDC 52544-080 and is authorized under FDA application ANDA040885.
Identification & Billing
- RxCUI: 1432261 - Fioricet 50 MG / 300 MG / 40 MG Oral Capsule
- RxCUI: 1432261 - acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG Oral Capsule [Fioricet]
- RxCUI: 1432261 - APAP 300 MG / butalbital 50 MG / Caffeine 40 MG Oral Capsule [Fioricet]
- RxCUI: 1432261 - Fioricet (acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG) Oral Capsule
- RxCUI: 1432261 - Fioricet (APAP 300 MG / butalbital 50 MG / caffeine 40 MG) Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 52544 - Actavis Pharma, Inc.
- 52544-080 - Fioricet
- 52544-080-01 - 100 CAPSULE in 1 BOTTLE
- 52544-080 - Fioricet
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 52544-080-01 identifies a specific commercial package of 100 capsule in 1 bottle of Fioricet, a human prescription drug labeled by Actavis Pharma, Inc.. This capsule is formulated for oral use and contains acetaminophen; butalbital; caffeine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Actavis Pharma, Inc. on July 29, 2013. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This combination medication is used to treat tension headaches. Acetaminophen helps to decrease the pain from the headache. Caffeine helps increase the effects of acetaminophen. Butalbital is a sedative that helps to decrease anxiety and cause sleepiness and relaxation.
How is this Actavis Pharma, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 52544008001. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.